FDA Inspection 1220425 — Swiss Bionic Solutions GmbH

Swiss Bionic Solutions GmbH — FEI 3007791564

The FDA completed an inspection of Swiss Bionic Solutions GmbH on September 28, 2023 in Schindellegi. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 6 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 28, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Schindellegi (Switzerland)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
310321 CFR 820.30(i)Design changes - Lack of or Inadequate Procedures
312521 CFR 820.80(d)Lack of or inadequate final acceptance procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
45421 CFR 820.40(a)Document review, approval by designated individual
63021 CFR 803.17Lack of Written MDR Procedures